LEGN
Legend Biotech Corp
19.90$
+5.7%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
Legend Biotech Corp (LEGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -61 | -96 | 16 | -1.7 | -76 | -82 | -104 | -13 | 29 | -106 | -85 | -21 | -183 | |
| 5.2 | 5.4 | 5.7 | 5.4 | 3.9 | 6.8 | 5.2 | 5.9 | 5.9 | 12 | 16 | 12 | 45 | |
| 12 | 13 | 19 | 22 | 15 | 13 | 16 | 19 | 15 | 15 | 19 | 17 | 67 | |
| -1.8 | -12 | 94 | 3.0 | 2.0 | -80 | -74 | -37 | 77 | -31 | -76 | -101 | -130 | |
| 5.5 | 6.8 | 6.2 | 3.4 | 2.1 | 2.4 | 2.0 | 9.2 | 5.0 | 21 | 26 | 21 | 73 | |
| -209 | 408 | -396 | -696 | 329 | -88 | 257 | -166 | -20 | 640 | -169 | -120 | 332 | |
| – | – | – | – | -1.2 | -0.9 | -0.8 | -1.3 | -0.6 | -1.0 | -1.3 | -45 | -48 | |
| 1.0 | 0.9 | 0.8 | 1.0 | 4.2 | -0.3 | 0.7 | -1.0 | 0.7 | -0.6 | -1.2 | 168 | 167 | |
| -270 | 314 | -380 | -696 | 258 | -173 | 155 | -175 | 12 | 623 | -255 | 27 | 406 | |
| -66 | -102 | 9.3 | -5.1 | -78 | -84 | -106 | -22 | 24 | -127 | -111 | -41 | -256 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.